GM-CSF instead of hematological support during high-dose chemotherapy for refractory malignant lymphoma. [electronic resource]
Producer: 19960319Description: 327-30 p. digitalISSN:- 1042-8194
- Adult
- Aged
- Agranulocytosis -- chemically induced
- Bone Marrow Transplantation
- Combined Modality Therapy
- Cyclophosphamide -- adverse effects
- Dose-Response Relationship, Drug
- Female
- Granulocyte-Macrophage Colony-Stimulating Factor -- adverse effects
- Hematopoietic Stem Cell Transplantation
- Humans
- Infusions, Intravenous
- Lymphoma, Non-Hodgkin -- blood
- Male
- Middle Aged
- Pilot Projects
- Platelet Transfusion
- Prognosis
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.